View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CMS RIN: 0938-AT91 Publication ID: Spring 2020 
Title: International Pricing Index Model For Medicare Part B Drugs (CMS-5528)(Section 610 Review) 
Abstract:

This proposed rule considers testing changes to payment for certain separately payable Part B drugs and biologicals.

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: No 
EO 13771 Designation: Regulatory 
RFA Section 610 Review: Section 610 Review 
CFR Citation: 42 CFR 513   
Legal Authority: Social Security Act, sec. 1115A   
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  10/30/2018  83 FR 54546   
ANPRM Comment Period End  12/31/2018 
NPRM  06/00/2020 
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: Federal, State 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: Yes 
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest.
RIN Data Printed in the FR: Yes 
Agency Contact:
Andrew York
Social Science Research Analyst
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Medicare and Medicaid Innovation, MS: WB-06-05, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-8945
Email: andrew.york1@cms.hhs.gov